Material
G ranzyme B (GrB) is a 32-kDa serine protease that is a key constituent in secretory granules of NK cells and CTLs (1, 2) . Five different human granzymes, seven in rats and 10 in mice, have been described to date (3, 4) . Classically, GrB is released via granule exocytosis toward target cells such as tumor or virus-infected cells where it induces apoptosis by cleaving the BH3-only proapoptotic protein Bid and/or processing of the effector caspase-3 (5, 6). The pore-forming molecule perforin plays a major role in this process as it facilitates delivery of granzymes into the target cell (7) (8) (9) . In mice, GrB expression has to date been described in T cells, NK cells, and their thymic precursors (10) . In contrast, recent evidence has linked human GrB to a broader spectrum of cells including CD34 + hematopoietic progenitor cells (11) , keratinocytes (12), basophils (13) , mast cells (14) , plasmacytoid dendritic cells (15) , and B cells (16) .
In human B cells, GrB is induced by IL-21 and is strongly enhanced by simultaneous BCR cross-linking. Notably, exposure to viral Ags can substitute for artificial BCR cross-linking and enhance the IL-21-induced GrB secretion from B cells of vaccinated human donors (16) . In a subsequent study, CD40L was found to play a determining role in this process: B cells secreted GrB in its absence but differentiated into plasma cells when it was present (17) . Moreover, malignant human B cells (chronic lymphocytic leukemia, B-CLL) secrete low levels of GrB upon triggering by either BCR cross-linking or CpG oligodeoxynucleotide (CpG ODN) combined with IL-21. These B cells were found to induce apoptosis in bystander B-CLL cells in a GrB-dependent manner (18) . Furthermore, a significant correlation between GrB and IL-21 serum levels has been found in patients with the autoimmune disease systemic lupus erythematosus. In these patients, GrB was constitutively expressed in CD5 + but not CD5 2 B cells (19) .
These various studies have revealed a novel function for IL-21 and strongly suggest a role for GrB expression in B cells, which may contribute to immunosurveillance, early antiviral immune response, and autoimmune pathogenesis. Furthermore, we hypothesized that the induced expression of GrB in B cells upon BCR cross-linking and exposure to IL-21 might play a role in the regulation of contraction of germinal center responses by eliminating helper populations such as follicular T helper cells. At this stage, however, there is little experimental evidence for the physiological importance of GrB expression in B cells or B cellmediated cytotoxicity. Hence, the aim of the current study was to establish a reliable mouse model further to study this interesting set of observations.
Materials and Methods
Mice, in vivo immunization, and viral infections 
Cell culture of mouse B cells
On day 10 (NP-KLH) or day 5 and day 10 (viral infections) after immunization, spleens and mediastinal lymph nodes were harvested from euthanized mice. Mononuclear cells were prepared from lymph nodes after red cell lysis and B cells purified from the spleen. B cell enrichment (96-99%) was achieved using a negative selection with Ab-coated beads (no. 130-090-862; Miltenyi Biotec, Bergisch Gladbach, Germany). NK cells were isolated from spleens of either B6.GrzmB 2/2 or C57BL/6 mice using MACS-based negative selection (Miltenyi Biotec) with subsequent separation on an autoMACS sorter. Media for primary cell culture consisted of RPMI 1640 medium supplemented with 2 mM glutamine, 50 mM 2-mercaptoethanol, 100 mM nonessential amino acids, 100 U/ml penicillin, 100 mg/ml streptomycin, 1 mM sodium pyruvate, 10 mM HEPES, and 10% FBS. Cells were plated on flat-bottom 96-well plates at 100,000 cells/ well/200 ml (spleen) or 25,000 cells/well/200 ml (lymph node) in the presence of reagents as follows: recombinant mouse IL-21 (100 ng/ml) and IL-4 (500 U/ml) (R&D Systems, Minneapolis, MN); CpG ODN 1668 (59-TCCATGACGTTCCTGATGCT-39; GeneWorks, Thebarton, SA, Australia) was used at a final concentration of 1 mM; LPS derived from Salmonella typhosa (Sigma-Aldrich, St. Louis, MO) and anti-CD40 (FGK4.5; The Walter and Eliza Hall Institute of Medical Research) were at 20 mg/ ml. BCR engagement in naive B cells was achieved by using Abs against IgM (clone b.7.6) and IgD (clone 1.19) at 10 mg/ml (kindly provided by Prof. Phil Hodgkin, The Walter and Eliza Hall Institute of Medical Research). For in vivo immunization experiments with NP-KLH, some cells were restimulated in vitro with plate-bound NP13-BSA at 5 mg/ml. In SW HEL -transgenic B cell cultures, hen egg lysozyme (HEL) was used for direct ligation of the BCR (100 ng/ml; Sigma-Aldrich).
NP ELISA
Serum of immunized B6.GrzmB 2/2 , C57BL/6, or naive mice was collected from the retro-orbital sinus on day 10, 14, and 21 after injection or on day 8 after boost (day 53). Concentrations on NP-specific total or high-affinity Abs were determined by ELISA. Briefly, 96-well flat-bottom plates were coated with 10 mg/ml NP13-BSA and NP14-BSA (for total Ab) and NP1-BSA and NP2-BSA (for high-affinity Ab) and incubated overnight at 4˚C. Standards and serum samples were added serially diluted in blocking buffer (PBS, 0.05% Tween-20, 0.6% milk, and 1% FBS) and incubated at room temperature overnight. Plates were then washed and incubated for 4 h at room temperature with a goat anti-mouse IgG 1 HRP secondary Ab (Southern Biotech, Birmingham, AL). After washing, tetramethylbenzidine substrate (Sigma-Aldrich) containing 0.01% H 2 O 2 (Merck, Darmstadt, Germany) was added, the reaction stopped with 1 M H 2 SO 4 , and plates were analyzed in an ELISA plate reader (VersaMax PLUS ROM v.1.21; Molecular Devices, Sunnyvale, CA) at 450 nm.
Human B cell culture
Human B cells were isolated using a MACS-based kit with negative selection (no. 130-091-151; Miltenyi Biotec). B cells (purity .99%) were resuspended in AIM-V medium (Invitrogen, Carlsbad, CA) and cultured on 96-well round-bottom plates at 200,000 cells/well/200 ml, if not stated otherwise. The following reagents were used as in vitro B cell stimuli: human recombinant IL-21 (50 ng/ml) was purchased from Invitrogen and affinity purified rabbit F(ab9) 2 against human IgA plus IgG plus IgM (H plus L) was used for polyclonal BCR stimulation at 6.5 mg/ml (anti-BCR; Jackson ImmunoResearch Laboratories). Non-B cells (= B cell-depleted fraction) were activated with a combination of 100 U/ml human recombinant IL-2 (Proleukin; National Cancer Institute, Bethesda, MD) and PHA [1 mg/ml (23, 24) ].
Intracellular GrB staining
After stimulation, brefeldin A (1 mg/ml; A.G. Scientific, San Diego, CA) was added for 4 h, and cells were harvested and stained as described previously (16) . For human studies, a PE-labeled Ab to GrB (clone GB11; Sanquin, Amsterdam, The Netherlands) was used, and for mouse B cells, an Alexa Fluor 647 mouse anti-human Ab (clone GB11; BD Biosciences, San Jose, CA). To exclude a lack of sensitivity for the Ab to detect GrB in mice, in all experiments NK cells from either C57BL/6 or B6.GrzmB 2/2 were activated over 4 d with IL-2 in 24-well plates at 700,000 cells/ml/well (1000 U/ml) and used as staining controls (Fig. 1B) . Cell surface markers were analyzed for some mouse experiments using B220-FITC, CD3-Pacific blue, or CD138-PE (BD Biosciences). Flow cytometry was performed on a FACSCanto or LSR device (BD Biosciences) and data analyzed using FlowJo software (version 8.8.7; Tree Star, Stanford, CA).
GrB secretion and activity assay C57BL/6 B cells were isolated and stimulated overnight with anti-IgM plus anti-IgD (= anti-BCR), anti-CD40 plus IL-4 with or without IL-21. The next day, cells were cultured for 4 h in the presence of PMA (1 mg/ml) and ionomycin (10 mg/ml), and culture supernatants were collected. Additionally, whole-cell lysates were prepared and normalized for protein content. GrB activity was determined by the hydrolysis of synthetic peptide thiobenzylester substrate (Asp-ase activity, Boc-Ala-Ala-Asp-S-Bzl; SM Biochemicals), as described previously (25, 26) . Supernatants of IL-2-stimulated NK cells or lysates of activated T cells from either C57BL/6 or B6.GrzmAB 2/2 were used as controls. T cells (2.5 3 10 7 cells/ml in 6-well plates) were stimulated with IL-2 (100 U/ml), IL-7 (2 ng/ml), and purified anti-CD3 and anti-CD28 (100 ng/ml; BD Biosciences) for 3 d. Cells were split on day 2 when fresh IL-2 was added.
Real-time RT-PCR
Murine or human B cells (2 3 10 6 ) were isolated and activated as described earlier. After culture, total RNA was obtained using the RNeasy mini kit (Qiagen, Doncaster, Australia) according to the manufacturer's methods. RNA was reverse-transcribed using M-MLV Reverse Transcriptase (RNase H Minus, Point Mutant) and oligonucleotide primer (both from Promega, Madison, WI). Real-time quantitative PCR was performed using an The 
Statistics
Data are expressed as mean 6 SEM. Statistical differences between the means of two data groups was determined by using the paired or unpaired Student t test, and p values ,0.05 were considered significant.
Results

Stimulation with IL-21 and BCR cross-linking induces GrB in human but not in murine B cells
In previous reports, we demonstrated that the IL-2 family cytokine IL-21 in combination with BCR ligation induces expression and secretion of the serine protease GrB in human B cells (16, 17, 19) . These studies suggested that GrB might play a significant role in the early anti-viral immune response and the control of autoimmunity. To enable more detailed studies of the underlying mechanisms, we investigated the induction of GrB in CFSE-labeled B cells from C57BL/6 mice in response to anti-CD40 plus IL-4 and BCR stimulation in the presence or absence of IL-21. When we analyzed the cells by flow cytometry, we found that unlike human B cells, murine B cells did not express GrB (Fig. 1A) , although they were activated and underwent multiple rounds of division after 48 h as demonstrated by dilution of CFSE (Supplemental Fig. 1 ). Furthermore, extending cultures for up to 3 d was not sufficient to induce GrB expression (data not shown). Similar results were found in B cells derived from BALB/c, CBA, or DBA/2 mice (Supplemental Fig. 2) . In all experiments, IL-2-activated NK cells from either B6.GrzmB 2/2 or C57BL/6 mice were used as negative or positive staining controls, respectively (Fig. 1B) . Human GrB was enzymatically active when secreted into B cell culture supernatants (17) and thus was confirmed once again by testing whole-cell lysates of activated human B cells for cleavage of the highly specific Ala-Ala-Asp substrate (Fig. 1C,  upper panel) ; however, neither proteolytic activity of cell lysates (Fig. 1C, lower panel) nor secretion of active GrB in cell culture supernatants (Supplemental Fig. 3 ) was detected when murine B cells were stimulated in a similar fashion. To determine whether the GrB gene is transcribed in mouse B cells, we measured GrB mRNA in stimulated B cells. In humans, GrB mRNA is not constitutively expressed but requires IL-21 and engagement of the BCR (Ref. 16 and Fig. 1D, upper panel) . In mice, however, GrB mRNA levels were not significantly different from those of GrBdeficient mice, in which the gene has been largely deleted (Fig. 1D , lower panel, Table I ). Similar results were obtained for GrA (whose gene is located on a separate chromosome) and GrC, the gene that is tightly linked to the GrB gene (data not shown).
Infection with influenza virus does not induce GrB in B cells
We recently demonstrated that restimulation of Ag-specific B cells from previously vaccinated human subjects with viral Ags triggered GrB expression (16) . We therefore tested GrB expression in the B cells of mice infected with influenza virus. Referring to previous studies, we hypothesized that GrB expression might bridge innate and adaptive immune responses (17) . Therefore, we tested an early time point postinfection (day 5) and at a time when a T cell response would be generated (day 10). As expected, infection with influenza induced GrB in cytotoxic T cells ex vivo, most notably by day 10, but we failed to detect the presence of GrB in B cells ( Fig. 2A, 2B ). The effect in T cells was enhanced by adding IL-21 and various other stimuli to cell cultures (Fig. 2C and data not shown). However, no GrB was detected in B cells at any time point, irrespective of the stimuli applied. To examine if exposure to persistent viral pathogens was required for GrB expression, we tested a second model of infection, murine g-herpesvirus. Similar to the results obtained with the influenza model, T cells expressed GrB after exposure to virus, whereas B cell populations did not (Supplemental Fig. 4 ).
Ag-specific mouse B cells lack expression of GrB
We next used the model B cell Ag NP-KLH to address the role of GrB in the humoral immune response. This model enabled us to engage both the B cell and IL-21 receptors and CD4 + follicular T helper cells that are known to be crucial for humoral immune responses during the germinal center reaction via the production of IL-21 (27) . Wild-type C57BL/6 and B6.GrzmB 2/2 mice were immunized i.p. with 50 mg NP-KLH Ag and spleens harvested 10 d after immunization. We first tested baseline GrB expression by incubating freshly purified B cells for 4 h with brefeldin A and subsequent testing for intracellular GrB by flow cytometry (Fig.   3A) .
plus IL-4, and CpG ODN 1668 to cover a wide spectrum of B cell activators. Direct antigenic restimulation as a highly specific stimulus was performed with plate-bound NP-KLH (Fig. 3B , with day 1 shown as a representative time point). Although all stimuli induced typical morphological changes indicating activation of the B cells (Supplemental Fig. 1 ), we could not detect intracellular GrB at any time point.
GrB is redundant for Ab responses to NP
The role of GrB in infection, cancer, and autoimmunity has been studied extensively (28) (29) (30) (31) ; however, it is still unclear whether GrB contributes to humoral immune responses, potentially by B cell-induced death of helper cells leading to the contraction of the germinal center. Thus, we collected serum from NP-KLHimmunized mice on day 10, 14, and 21 after primary immunization or on day 8 after boost (day 53 after first injection) and tested for total Ab and high-affinity Abs to NP. We found no significant difference between wild-type and B6.GrzmB 2/2 mice in either response (Fig. 3C, 3D ).
Direct ligation of SW HEL -transgenic BCRs fails to induce GrB in B cells
As BCR cross-linking appears to play a fundamental role in GrB induction in human B cells (16, 17) , we applied a transgenic mouse model that enabled us to test Ag-specific BCR stimulation. B cells from SW HEL -transgenic mice produce Abs of high affinity to HEL and can undergo Ig class switch recombination and somatic hypermutation (32) . We bred this model onto a RAG 2/2 background so that all B cells expressed a specific BCR against HEL. IL-21 and simultaneous expression of CD40L has previously been shown to induce differentiation of B cells to plasma cells in a CD4 + T cell-dependent manner (33) . We recently showed that B cells secreted GrB when stimulated by IL-21, but only if CD40 The Journal of Immunologyligation is absent (17) . Similarly, B cells from SW HEL mice differentiate into plasma cells when stimulated with LPS, but not when soluble HEL is added to the culture (34, 35) . We hypothesized that ligation of the BCR in these cultures might contribute to the loss of plasma cells by inducing GrB-secreting B cells. B cells were purified from SW HEL mice, cultured for 4 d with LPS, anti-CD40 plus IL-4 and CpG ODN 1668, with or without IL-21 and soluble HEL. B cells were then stained for intracellular GrB and for expression of the plasma cell marker CD138. We observed no induction of GrB expression in the presence of HEL (Fig. 4A) , although engaging the BCR with soluble HEL induced the expected loss of plasma cells (Fig. 4B) .
Discussion
To date, GrB expression in human B cells has been described in the context of viral infections (16) , autoimmunity (19) , and cancer (18), suggesting a regulatory or modifying role in these diseases. Yet, exact mechanisms involved in GrB expression of B cells and the physiological relevance of these findings require further investigation. In the absence of a recognized syndrome of human granzyme deficiency, mouse models have been invaluable for our understanding of granzyme biology. For example, GrzmB 2/2 mice survive most experimental virus infections (36, 37) , but the combined loss of GrA and GrB results in a severe immunological defect revealed by infection with poxviruses such as ectromelia (38, 39) .
We reasoned that if human B cells express GrB, it is likely that certain stimuli will bring about a similar effect in murine B cells. However, we failed to detect GrB or its proteolytic activity using a variety of assays in mouse B cells stimulated with B cell activators in combination with IL-21, the most potent inducer of GrB in human B cells (16) . We combined IL-21 with various other B cell stimuli including engagement of IgM and IgD in naive B cells. Subsequently, IL-4 in combination with CD40 ligation, LPS, and CpG ODN 1668 were tested to induce proliferation and isotype switching. To specifically address BCR engagement, we tested B cells with a transgenic BCR (SW HEL ). We also extended our studies into several in vivo models with viral infections and immunization with a specific Ag, the latter an extensively used system for studying B cell responses in vivo (40) (41) (42) . Infection with either influenza or murine g-herpesvirus did not induce GrB in B cell populations, and GrB deficiency did not alter B cell Ab production in vivo. Additionally, we tested mouse B cells in these models for constitutive expression of GrB, as we found baseline GrB expression in CD5 + B cells from patients with systemic lupus erythematosus (19) . All of the conditions, however, failed to induce GrB expression in B cells. We therefore conclude that the mechanisms regulating GrB expression are not conserved between humans and mice.
Human and mouse GrB have previously been shown to possess a number of important functional and phenotypic differences. For example, mouse GrB is 30 times less cytotoxic than human GrB, activates distinct apoptotic pathways (43) , and exhibits significantly different substrate specificities (44, 45) . This raises the likelihood that mouse and human GrB may have developed species-specific functions in response to particular evolutionary pressures. This hypothesis is further supported by the fact that human GrB has multiple functional paralogues in the mouse suggesting that the various functions of human GrB might be split between different granzymes in rodents. For example, the downstream "orphan" GrC and/or GrF have reported functions in mouse CTL/NK cytotoxicity, whereas the equivalent role in humans is probably played by GrH (46-48) . Furthermore, GrB and its specific inhibitor serpin PI9 are found in the human testis and may play a role in reproduction (49) , whereas in mice GrN (and not GrB) is found in this organ (50) . GrB also shows extensive polymorphism in wild mice (51) , whereas only three common human GrB alleles have been identified (52) . To exclude strain differences, we also tested CBA, DBA/2, and BALB/c mice, but we found no expression of GrB.
In conclusion, the current study indicates that findings on GrB cannot be generalized from one species to another. The physiological and pathological relevance of GrB expression in human B cells still remains unclear, but mouse models are unlikely to provide insight into these processes. Our study demonstrates the need to develop novel in vivo systems to study human immune responses.
